Category: Diabetes/Prediabetes/Hypoglycemia

Monitor: 11

11 - CLINICAL EXPERIENCE IN THE USE OF GLP 1 ANALOGS IN AN ENDOCRINOLOGY OUTPATIENT CLINIC IN TEGUCIGALPA, HONDURAS

Thursday, Apr 25
11:00 AM – 11:30 AM

Objective : To characterize type 2 diabetes patients treated with GLP1 analogs in the outpatient clinic of endocrinology in Honduras Medical Center from 2016-2018. 


Methods :

This is a retrospective descriptive study, evaluating 29 patients with type 2 diabetes, collecting data from the medical files that was introduced to a SPSS data base. Data was analyzed using descriptive statistics and cross tabulations. 


Results : Most 58.6% (n=17) were females, and 41.4% were males, with a mean age of 45. Twenty six (88.8%) of the studied patients have 10 years or less of type 2 diabetes diagnosis. The mean of time exposure to  GLP1 was 14 months, with a mean of A1c at the beginning of the study was 7.69%, managing to accomplish a descent of 1.7% during the study. The mean weight of the studied patients was 97.2kg with a mean decrease of 2.5kg. The most frequent adverse effect was nausea, and there were no reported cases of hypoglycemia, pancreatitis, diarrhea, or infection on the injection site. 


Discussion : The decrease in A1c is found to be within the expected range of descent (0.6-1.9%), and patients consistently presented gradual weight loss that was sustained during the duration of the study with minor adverse effects. 


Conclusion : There have not been a lot of published experiences in latin american population living in central america with this new family of medications and this brief description seems to show a tendency that is in agreement with what is reported in world literature.

SHORT URL FUNCTION-->

Maria Alejandra Ramos Guifarro

Chief of Endocrinology
Hospital Escuela Universitario
Tegucigalpa, Francisco Morazan, Honduras

Chief of Endocrinology Hospital Escuela

Irma De Vicente

Internal Medicine
Hospital Escuela Universitario

.

Scarleth Betzabel Rodas

Medical Student
Universidad Nacional autonoma de Honduras

.

Daniel Andrés Guifarro Rivera

Medical Student
Universidad Nacional Autónoma de Honduras
Tegucigalpa, Francisco Morazan, Honduras

8th Year Medical Student